Patents Assigned to Janssen Alzheimer Immunotherapy
  • Humanized antibodies that recognize beta amyloid peptide
    Patent number: 7625560
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A? in the brain of a patient. Preferred agents include antibodies, e.g., humanized antibodies.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: December 1, 2009
    Assignee: Janssen Alzheimer Immunotherapy
    Inventors: Guriq Basi, Jack Steven Jacobsen